SPAC bust: ARCH, Deer­field and Sec­tion 32 can­cel their $200M life sci­ences bet

A life sci­ences SPAC backed by in­dus­try in­vestors Sec­tion 32, Deer­field Man­age­ment and ARCH Ven­ture Part­ners is clos­ing shop well af­ter the blank-check fad end­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.